to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease.
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Hepatitis C infection in liver transplantation.
Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?
Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.
Recurrence of hepatitis C infection: Where are we now?
Branched-chain amino acid enriched supplements as therapy for liver disease.
Perioperative viral kinetics: new insights or the Emperor's new clothes?
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.
Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation.
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.
Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
Acute-On-Chronic Liver Failure